Last Funding Type: Series E
Funding Status: IPO
Headquarters: Emeryville, California, United States
Founded Date: 2011-01-01
Last Funding Date: 2018-10-10
Total Funding: 267567756.0
Technology: Biopharma, Biotechnology, Genetics, Health Care, Therapeutics
Employee Number: 101-250
Estimated Revenue: $50M to $100M
Investors Number: 14.0
Industry: Preclinical Development